Report overview
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report contains market size and forecasts of Gene-based Advanced Therapy Medicinal in Global, including the following market information:
Global Gene-based Advanced Therapy Medicinal Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Gene-based Advanced Therapy Medicinal market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Viral Gene Delivery System Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Gene-based Advanced Therapy Medicinal include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene-based Advanced Therapy Medicinal companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene-based Advanced Therapy Medicinal Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, by Type, 2022 (%)
Viral Gene Delivery System
Non-viral Gene Delivery System
Global Gene-based Advanced Therapy Medicinal Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, by Application, 2022 (%)
Neurological Diseases
Cancer
Other
Global Gene-based Advanced Therapy Medicinal Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene-based Advanced Therapy Medicinal revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene-based Advanced Therapy Medicinal revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
